64/100B39.440
USD
-0.54
(-1.35%)
Market Closed
Last updated: · Delayed 15 min
Medline EPS (earnings per share) 2022–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Medline's diluted EPS in Q3 FY2026, the three months to 26 September 2026, was 0.22 USD, down 46.3% on the same quarter a year before. Medline's diluted earnings per share in fiscal year 2025 were -0.01 USD, down 100.7% on the year before.
Last updated 9 Nov 2026 · Next report 24 Feb 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 26 Sept 2026 | 0.67 | — | 0.67 |
| FY2025 | 31 Dec 2025 | -0.01 | -100.66% | 1.43 |
| FY2024 | 31 Dec 2024 | 1.52 | +406.67% | 1.52 |
| FY2023 | 31 Dec 2023 | 0.30 | — | 0.30 |
| FY2022 | 31 Dec 2022 | -0.03 | — | -0.03 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 26 Sept 2026 | 0.22 | -46.34% | 0.22 |
| Q2 FY2026 | 27 Jun 2026 | 0.07 | -83.33% | 0.07 |
| Q1 FY2026 | 31 Mar 2026 | 0.16 | -60.00% | 0.16 |
| Q4 FY2025 | 31 Dec 2025 | 0.22 | — | 0.22 |
| Q3 FY2025 | 30 Sept 2025 | 0.41 | 0.00% | 0.41 |
| Q2 FY2025 | 30 Jun 2025 | 0.42 | +13.51% | 0.42 |
| Q1 FY2025 | 31 Mar 2025 | 0.40 | — | 0.40 |
| Q3 FY2024 | 30 Sept 2024 | 0.41 | — | 0.41 |
| Q2 FY2024 | 30 Jun 2024 | 0.37 | — | 0.37 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement
Common questions about Medline's EPS
Source: Financial Modeling Prep